Apyx Medical Corporation (APYX) vs Insight Molecular Diagnostics Inc. (IMDX)
A side-by-side comparison of Apyx Medical Corporation and Insight Molecular Diagnostics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
APYX
Apyx Medical Corporation
$2.62HealthcareDelayed quote: Oct 6, 2026, 12:43 PM EDT
IMDX
Insight Molecular Diagnostics Inc.
$3.50HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
Total return — APYX vs IMDX
growth of $100 · dividends reinvested · last 8yAPYX -59.8% (-10.8%/yr)IMDX -87.5% (-22.9%/yr)APYX compounded faster over this window
APYX IMDX
APYX vs IMDX: by the numbers
- •IMDX is the larger company ($113M vs $110M market cap).
- •Both run net losses; APYX's is the smaller (-14.78% vs -2955.63% net margin).
- •IMDX grew revenue faster over the past five years (27.24% vs 8.82% CAGR).
Metrics side by side
Valuation
| Metric | APYX | IMDX |
|---|---|---|
| P/S ratio | 1.89 | 67.67 |
| P/B ratio | 10.33 | N/A |
Profitability
| Metric | APYX | IMDX |
|---|---|---|
| Gross margin | 33.94% | 11.17% |
| Operating margin | -6.06% | -754.08% |
| Net margin | -14.78% | -2955.63% |
| ROE | -80.97% | N/A |
| ROIC | -6.84% | -223.06% |
Growth (annualized)
| Metric | APYX | IMDX |
|---|---|---|
| Revenue CAGR (5Y) | 8.82% | 27.24% |
| Total return CAGR (5Y) | -28.10% | -44.39% |
Frequently asked
- Which has grown faster, APYX or IMDX?
- Over the past five years, IMDX grew revenue faster — APYX at a 8.82% CAGR versus IMDX at 27.24%.
- How have APYX and IMDX total returns compared?
- Over the past 5 years, APYX delivered -28.10% and IMDX delivered -44.39% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Apyx Medical ROEInsight Molecular Diagnostics ROEApyx Medical operating marginInsight Molecular Diagnostics operating marginApyx Medical revenue growthInsight Molecular Diagnostics revenue growthApyx Medical free cash flowInsight Molecular Diagnostics free cash flow
Apyx Medical & Insight Molecular Diagnostics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.